Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

ClinicalTrials.gov ID: NCT00530764

Public ClinicalTrials.gov record NCT00530764. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double Blind, Randomized, Placebo Controlled, Parallel Group Dose-range Exploration Study of Sativex® in Relieving Pain in Patients With Advanced Cancer, Who Experience Inadequate Analgesia During Optimized Chronic Opioid Therapy.

Study identification

NCT ID
NCT00530764
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
GW Pharmaceuticals Ltd
Industry
Enrollment
360 participants

Conditions and interventions

Interventions

  • Sativex High Dose Drug
  • Sativex Low Dose Drug
  • Sativex Medium Dose Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2007
Primary completion
Dec 31, 2009
Completion
Dec 31, 2009
Last update posted
Jun 19, 2013

2007 – 2010

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Cancer Care Center of Tuscaloosa Tuscaloosa Alabama 35406
Desert Oasis Cancer Center Casa Grande Arizona 85222
Pacific Coast Hematology/Oncology Medical Group, Inc. Fountain Valley California 92708
Office of Dr. Ronald Yanagihara Gilroy California 95020
University of California San Diego La Jolla California 92037
Loma Linda University Loma Linda California 92354
Florida Institute of Medical Research Jacksonville Florida 32257
Clinical Pharmacology Services Tampa Florida 33617
Center of Hope for Cancer and Blood Disorders Riverdale Georgia 30274
Louisiana Research Associates New Orleans Louisiana 70114
The Center for Clinical Research - Washington County Hospital Hagerstown Maryland 21740
Capital Comprehensive Cancer Care Clinic Jefferson City Missouri 65109
A & A Pain Institute of St. Louis St Louis Missouri 63141
Office of Donald H. Berdeaux MD Great Falls Montana 59405
Summit Medical Group Berkeley Heights New Jersey 07922
Beth Israel Medical Center New York New York 10003
Metropolitan Hospital Center New York New York 10029
Four Seasons Hospice & Pallative Care Flat Rock North Carolina 28731
Center for Clinical Research Winston-Salem North Carolina 27103
Gabrail Cancer Center Canton Ohio 44718
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232
Lone Star Oncology Austin Texas 78759
Huntsman Cancer Institute Salt Lake City Utah 84112

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 87 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00530764, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2013 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00530764 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →